ClinicalTrials.Veeva

Menu

Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy

K

Kantonsspital Winterthur KSW

Status

Completed

Conditions

Urolithiasis
Renal Hematoma

Treatments

Drug: Acetylsalicylic acid
Drug: low molecular weight heparin

Study type

Observational

Funder types

Other

Identifiers

NCT02875717
2015-0662/PB_2016-00897

Details and patient eligibility

About

Retrospective Analysis of patients that received shockwave lithotripsy as Treatment of ureteral or kidney Stones. Condition examinated is the effect of low molecular weight Heparins and acetylsalicylic acid on the Formation of renal hematoma after shockwave lithotripsy. Primary outcome is documented hematoma in a postoperative ultrasound control. Secondary outcomes are perioperative complication, Need for erythrocyte tranfusion, interventions for bleeding control, readmission or death within 30 days.

Enrollment

500 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • consent
  • Stones in kidney and proximal Ureter
  • Treatment with shockwave lithotripsy for urolithiasis between January 2009 and September 2015 at Kantonsspital Winterthur

Exclusion criteria

  • other Position of ureteral Stones
  • missing data in Patient reports
  • refused consent
  • under Age limit

Trial design

500 participants in 3 patient groups

Control
Acetylsalicylic acid
Description:
Patients that were on medication with Acetylsalicylic acid on the date of shockwave lithotripsy
Treatment:
Drug: Acetylsalicylic acid
Low Molecular weight heparin
Description:
Patients that were on medication with low molecular heparin on the date of shockwave lithotripsy
Treatment:
Drug: low molecular weight heparin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems